ACIP

(redirected from Asymptomatic Cardiac Ischemia Pilot Study)
Also found in: Wikipedia.

ACIP

Asymptomatic Cardiac Ischemia Pilot Study. A trial comparing outcomes of coronary artery bypass grafting (CABG) and percutaneous transluminal angioplasty (PTCA), using 3 therapeutic strategies for reducing myocardial ischaemia during exercise testing.
Primary endpoint Suppression of ischaemia on 48-hour Holter at 12 weeks
Conclusion EKG ischaemia was no longer present in 39% of those with the angina-guided strategy, 41% of those with the ischaemia-guided strategy and 55% of those with the revascularisation strategy; despite more severe coronary disease and more ischaemic episodes at baseline, ischaemia was lower in CABG patients than in PTCA patients, a finding maintained at 1 year.

ACIP

Cardiology A clinical trial–Asymptomatic Cardiac Ischemia Pilot Study that evaluated 3 therapeutic strategies2 for ↓ myocardial ischemia during exercise testing. See Angina, Coronary artery disease, Myocardial infarction, Silent ischemia Immunology Advisory Committee on Immunization Practices.

ACIP

The Advisory Committee on Immunization Practices of the U.S. Public Health Service.
Full browser ?